Abstract: The present invention provides a pharmaceutical composition comprising a pharmaceutically effective amount of human epidermal growth factor (EGF) and an amount of a pharmaceutically acceptable metal cation, such as zinc, which is sufficient to prevent the degradation of said EGF.

Abstract: A rotary switch, adapted to be secured to a panel, comprises a stator having a bearing flange provided with a cylindrical side wall and an underside; a circumferential groove provided in the side wall and an annular groove provided in the underside; and a rotor extending over the bearing flange and having a cylindrical side wall surrounding the cylindrical side wall of the bearing flange. The rotor is rotatably supported on and relative to the stator. There are further provided a stationary contact mounted in the stator; a movable contact carried by the rotor for displacement relative to the stationary contact upon turning of the rotor; and a first sealing ring received in the circumferential groove and projecting radially outwardly from the cylindrical side wall of the bearing flange. The first sealing ring sealingly and slidably engages the cylindrical side wall of the rotor.